Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael H. Silverman, MD
Biostrategics Consulting Ltd
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Jonesboro, Arkansas, United States
- Facility name not stated
Castro Valley, California, United States
- Facility name not stated
Davis, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Napa, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Santa Rosa, California, United States
- Facility name not stated
Sylmar, California, United States
- Facility name not stated
Vacaville, California, United States
- Facility name not stated
Norwalk, Connecticut, United States
- Facility name not stated
Coral Gables, Florida, United States
- Facility name not stated
Doral, Florida, United States
- Facility name not stated
Hialeah, Florida, United States
- Facility name not stated
Homestead, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Largo, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Miami Lakes, Florida, United States
- Facility name not stated
Miami Shores, Florida, United States
- Facility name not stated
Pinellas Park, Florida, United States
- Facility name not stated
Evans, Georgia, United States
- Facility name not stated
North Chicago, Illinois, United States
- Facility name not stated
Hutchinson, Kansas, United States
- Facility name not stated
New Orleans, Louisiana, United States
- Facility name not stated
Mineola, New York, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Wilmington, North Carolina, United States
- Facility name not stated
Duncansville, Pennsylvania, United States
- Facility name not stated
York, Pennsylvania, United States
- Facility name not stated
Columbia, South Carolina, United States
- Facility name not stated
El Paso, Texas, United States
- Facility name not stated
Fort Worth, Texas, United States
- Facility name not stated
Lewisville, Texas, United States
- Facility name not stated
Salt Lake City, Utah, United States
- Facility name not stated
St. George, Utah, United States
- Facility name not stated
Roanoke, Virginia, United States
- Facility name not stated
Richland, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 31 Jul 2016
- Completion
- 31 Jul 2016
- Last update posted
- 14 Jun 2017
- Registered enrollment
- 200
- Registry id
- NCT01594762
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.